US Stock MarketDetailed Quotes
ELAT Elanco Animal Health-TEU
- 21.320
- 0.0000.00%
Close Jan 31 16:00 ET
10.53BMarket Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open21.320Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)494.10MShares21.53052wk High1.56P/B10.53BFloat Cap19.13052wk Low--Dividend TTM494.10MShs Float49.458Historical High--Div YieldTTM0.00%Amplitude17.451Historical Low--Avg Price1Lot Size
Elanco Animal Health-TEU Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 112.36%189M | 109.40%312M | -381.82%-62M | 1,278.05%483M | 339.78%223M | 179.46%89M | -6.88%149M | 450.00%22M | -118.30%-41M | -173.69%-93M |
| Net income from continuing operations | 52.88%-49M | 89.52%-22M | 178.69%48M | 15.71%-472M | 69.97%-97M | 22.96%-104M | -296.23%-210M | -24.49%-61M | -923.53%-560M | -3,336.17%-323M |
| Operating gains losses | --4M | --14M | --1M | 102.26%5M | --3M | --0 | ---- | ---- | ---221M | --0 |
| Depreciation and amortization | -1.76%167M | 0.59%171M | -12.87%176M | 38.49%716M | -21.62%174M | 27.82%170M | 112.50%170M | 146.34%202M | 64.65%517M | 167.79%222M |
| Deferred tax | 180.00%4M | 64.63%-29M | 65.63%-11M | -23.20%-154M | -200.00%-35M | 93.90%-5M | -54.72%-82M | -28.00%-32M | ---125M | 334.90%35M |
| Other non cash items | 712.50%65M | 1,655.56%140M | -81.94%13M | -36.36%70M | -101.61%-1M | -81.40%8M | -250.00%-9M | 7,300.00%72M | 1,016.67%110M | 675.00%62M |
| Change In working capital | 71.70%-15M | -442.86%-38M | -80.87%-331M | -152.73%-87M | 223.81%156M | -162.35%-53M | -103.24%-7M | -1,730.00%-183M | 172.37%165M | -423.08%-126M |
| -Change in receivables | ---- | ---- | ---- | -278.57%-25M | ---- | ---- | ---- | ---- | 108.14%14M | ---- |
| -Change in inventory | ---- | ---- | ---- | 128.42%27M | ---- | ---- | ---- | ---- | -179.41%-95M | ---- |
| -Change in payables and accrued expense | ---- | ---- | ---- | -132.52%-120M | ---- | ---- | ---- | ---- | 1,372.41%369M | ---- |
| -Change in other current assets | ---- | ---- | ---- | 117.89%22M | ---- | ---- | ---- | ---- | -1,857.14%-123M | ---- |
| -Change in other working capital | ---- | ---- | ---- | --9M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 112.36%189M | 109.40%312M | -381.82%-62M | 1,278.05%483M | 339.78%223M | 179.46%89M | -6.88%149M | 450.00%22M | -118.30%-41M | -173.69%-93M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 91.61%-37M | -48.00%-37M | -390.00%-29M | 88.91%-530M | 0.00%-74M | 90.61%-441M | -327.27%-25M | 150.00%10M | -1,933.62%-4.78B | 0.67%-74M |
| Net PPE purchase and sale | -4.00%-26M | -52.94%-26M | -5.56%-19M | -73.02%-109M | -4.26%-49M | 28.57%-25M | -153.13%-17M | -38.46%-18M | 55.00%-63M | 47.89%-47M |
| Net intangibles purchase and sale | ---20M | 12.50%-7M | 81.58%-7M | 59.66%-71M | 10.71%-25M | --0 | 71.43%-8M | -18.75%-38M | -208.77%-176M | -34.62%-28M |
| Net business purchase and sale | 102.65%11M | --0 | --0 | 92.51%-342M | --0 | 90.91%-415M | --0 | --73M | -13,736.36%-4.57B | --0 |
| Net other investing changes | -100.00%-2M | ---4M | 57.14%-3M | -130.77%-8M | --0 | 85.71%-1M | --0 | ---7M | 620.00%26M | -7.36%34M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 91.61%-37M | -48.00%-37M | -390.00%-29M | 88.91%-530M | 0.00%-74M | 90.61%-441M | -327.27%-25M | 150.00%10M | -1,933.62%-4.78B | 0.67%-74M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -173.16%-169M | -43.28%-96M | -10,100.00%-200M | -95.76%210M | 344.44%44M | -94.32%231M | -1,057.14%-67M | -99.78%2M | 1,724.26%4.95B | -181.25%-18M |
| Net issuance payments of debt | -166.38%-154M | -32.84%-89M | -730.00%-189M | -95.40%177M | 0.00%-18M | -94.44%232M | -857.14%-67M | 110.27%30M | 3,283.47%3.85B | -200.00%-18M |
| Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --1.22B | --0 |
| Net other financing activities | -1,400.00%-15M | ---7M | 60.71%-11M | 127.97%33M | --62M | 99.01%-1M | --0 | 9.68%-28M | 35.87%-118M | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -173.16%-169M | -43.28%-96M | -10,100.00%-200M | -95.76%210M | 344.44%44M | -94.32%231M | -1,057.14%-67M | -99.78%2M | 1,724.26%4.95B | -181.25%-18M |
| Net cash flow | ||||||||||
| Beginning cash position | -12.59%507M | -33.59%342M | 26.09%638M | 46.67%506M | -32.49%453M | -58.63%580M | -57.68%515M | 46.67%506M | -49.12%345M | 109.49%671M |
| Current changes in cash | 85.95%-17M | 214.04%179M | -955.88%-291M | 21.64%163M | 204.32%193M | 83.65%-121M | -67.98%57M | -96.14%34M | 142.41%134M | -508.39%-185M |
| Effect of exchange rate changes | -400.00%-30M | -275.00%-14M | 80.00%-5M | -214.81%-31M | -140.00%-8M | -166.67%-6M | 14.29%8M | -177.78%-25M | 258.82%27M | 194.79%20M |
| End cash Position | 1.55%460M | -12.59%507M | -33.59%342M | 26.09%638M | 26.09%638M | -32.49%453M | -58.63%580M | -57.68%515M | 46.67%506M | 46.67%506M |
| Free cash flow | 123.44%143M | 125.00%279M | -158.82%-88M | 181.25%286M | 155.00%132M | 129.63%64M | -14.48%124M | 17.07%-34M | -1,403.70%-352M | -1,678.95%-240M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg